Lakeland Industries (LAKE) reported $193M in revenue for fiscal 2025, +15.2% year on year. That ranks #2673 by revenue among 2853 SEC filers and #288 in Healthcare. It posted a net loss of −$25.3M for the same year. Revenue has grown 5.6% a year on average since 2012 ($95.1M then). The fiscal 2025 balance sheet shows $210M in total assets, $12.5M in cash and $30.4M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $193M | +15.2% | FY20252026-01-31 |
| Gross profitGrossProfit | $63.3M | −7.8% | FY20252026-01-31 |
| Operating incomeOperatingIncomeLoss | −$15.5M | −$6.2M | FY20252026-01-31 |
| Net incomeNetIncomeLoss | −$25.3M | −$7.2M | FY20252026-01-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | −$15.8M | +$131,000 | FY20252026-01-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $671,000 | −56.4% | FY20252026-01-31 |
| Total assetsAssets | $210M | −1.2% | FY20252026-01-31 |
| Shareholders' equityStockholdersEquity | $129M | −11.9% | FY20252026-01-31 |
| CashCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $12.5M | −28.4% | FY20252026-01-31 |
| Long-term debtLongTermDebt | $30.4M | +85.0% | FY20252026-01-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-04-30 | $47.4M | $369,000 | Open → |
| Q2 20262026-07-31 | $50.1M | −$4.9M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Lakeland Industries Inc
- Ticker
- LAKE
- Exchange
- Nasdaq
- SIC classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- Fiscal year end
- 01-31
- CIK
- 0000798081
Filings
- 10-QSep 9, 2026Open filing →
- 10-QJun 9, 2026Open filing →
- 10-KApr 16, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| ValnevaVALN | $197M | −$130M |
| Strata Critical MedicalSRTA | $197M | $41.3M |
| LifemdLFMD | $194M | −$11.2M |
| Lakeland IndustriesLAKE | $193M | −$25.3M |
| BioteBTMD | $192M | $27.0M |
| Rhythm PharmaceuticalsRYTM | $190M | −$196,539 |
| Maravai LifesciencesMRVI | $186M | −$131M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Lakeland Industries — Key figures |url=https://companiesranked.com/en/company/lakeland-industries |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Lakeland Industries — Key figures. CompaniesRanked. https://companiesranked.com/en/company/lakeland-industriesBibTeX
@misc{companiesranked-en-company-lakeland-industries-2026,
author = {{CompaniesRanked}},
title = {{Lakeland Industries — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/lakeland-industries}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-159176 · April 16, 2026
{{cite web |title=Lakeland Industries — Key figures — 10-K (0001193125-26-159176) |url=https://www.sec.gov/Archives/edgar/data/798081/000119312526159176/lake-20260131.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-04-16}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.